AU6930200A - Use of lentiviral vectors for antigen presentation in dendritic cells - Google Patents
Use of lentiviral vectors for antigen presentation in dendritic cellsInfo
- Publication number
- AU6930200A AU6930200A AU69302/00A AU6930200A AU6930200A AU 6930200 A AU6930200 A AU 6930200A AU 69302/00 A AU69302/00 A AU 69302/00A AU 6930200 A AU6930200 A AU 6930200A AU 6930200 A AU6930200 A AU 6930200A
- Authority
- AU
- Australia
- Prior art keywords
- dendritic cells
- antigen presentation
- lentiviral vectors
- lentiviral
- vectors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000030741 antigen processing and presentation Effects 0.000 title 1
- 210000004443 dendritic cell Anatomy 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/464838—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0639—Dendritic cells, e.g. Langherhans cells in the epidermis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38471999A | 1999-08-27 | 1999-08-27 | |
US09384719 | 1999-08-27 | ||
PCT/US2000/023162 WO2001016342A1 (fr) | 1999-08-27 | 2000-08-23 | Utilisation de vecteurs lentiviraux pour la presentation de l'antigene dans les cellules dendritiques |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6930200A true AU6930200A (en) | 2001-03-26 |
Family
ID=23518472
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU69302/00A Abandoned AU6930200A (en) | 1999-08-27 | 2000-08-23 | Use of lentiviral vectors for antigen presentation in dendritic cells |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1214437A1 (fr) |
AU (1) | AU6930200A (fr) |
CA (1) | CA2392010A1 (fr) |
WO (1) | WO2001016342A1 (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000039304A2 (fr) | 1998-12-31 | 2000-07-06 | Chiron Corporation | Polynucleotides codant pour des polypeptides antigeniques du type c du vih; polypeptides et leurs utilisations |
US7211659B2 (en) | 2001-07-05 | 2007-05-01 | Chiron Corporation | Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
CN1708320A (zh) * | 2002-11-07 | 2005-12-14 | 郎基·常 | 经修饰的树突状细胞 |
AU2006252406B2 (en) * | 2005-06-01 | 2012-05-17 | California Institute Of Technology | Method of targeted gene delivery using viral vectors |
WO2008011636A2 (fr) | 2006-07-21 | 2008-01-24 | California Institute Of Technology | Administration de gène ciblée pour une vaccination des cellules dendritiques |
EP2456786B2 (fr) | 2009-07-24 | 2017-04-19 | Immune Design Corp | Vecteurs lentiviraux pseudotypés avec une glycoprotéine d'enveloppe de virus sindbis |
US9713635B2 (en) | 2012-03-30 | 2017-07-25 | Immune Design Corp. | Materials and methods for producing improved lentiviral vector particles |
US8323662B1 (en) | 2012-03-30 | 2012-12-04 | Immune Design Corp. | Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein |
ES2707288T3 (es) | 2012-03-30 | 2019-04-03 | Immune Design Corp | Partículas de vectores lentivíricos que tienen eficiencia de transducción mejorada para células que expresan DC-SIGN |
US9493789B2 (en) * | 2014-04-24 | 2016-11-15 | Miltenyi Biotec Gmbh | Automated generation of genetically modified stem cells |
MX2018015593A (es) | 2016-06-16 | 2019-06-06 | Nuseed Pty Ltd | Canola evento elite ns-b50027-4. |
GB202105278D0 (en) * | 2021-04-13 | 2021-05-26 | Imperial College Innovations Ltd | Cell therapy |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1007716A4 (fr) * | 1997-04-17 | 2000-06-14 | Univ California | Utilisation de vecteurs lentiviraux pour l'introduction d'un antigene dans des cellules dendritiques |
-
2000
- 2000-08-23 CA CA002392010A patent/CA2392010A1/fr not_active Abandoned
- 2000-08-23 AU AU69302/00A patent/AU6930200A/en not_active Abandoned
- 2000-08-23 WO PCT/US2000/023162 patent/WO2001016342A1/fr not_active Application Discontinuation
- 2000-08-23 EP EP00957722A patent/EP1214437A1/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2392010A1 (fr) | 2001-03-08 |
EP1214437A1 (fr) | 2002-06-19 |
WO2001016342A1 (fr) | 2001-03-08 |
WO2001016342A9 (fr) | 2002-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7158398A (en) | Use of lentiviral vectors for antigen presentation in dendritic cells | |
AU5731400A (en) | Methods of preparing electrochemical cells | |
AU1796601A (en) | Methods of preparing electrochemical cells | |
AU2001259624A1 (en) | Modulation of antigen processing using phagocytic cells | |
AU2002322211A1 (en) | Methods and compisitions for activation human t cells in vitro | |
AU2001274920A1 (en) | Mammalian receptor proteins; related reagents and methods | |
AU6140998A (en) | Peptides and peptide-loaded antigen presenting cells for the activation of ctl | |
AU1951201A (en) | Peptide antigens | |
AU2001260847A1 (en) | Compositions isolated from skin cells and methods for their use | |
AU4191600A (en) | An eeprom cell on soi | |
AU2403901A (en) | Maturation-promoting agent for immature dendritic cells | |
AU6930200A (en) | Use of lentiviral vectors for antigen presentation in dendritic cells | |
AU2001233132A1 (en) | Hybrid adeno-retroviral vector for the transfection of cells | |
AU2001292617A1 (en) | Mammalian receptor genes and uses | |
AU1919201A (en) | Mammalian receptor proteins; related reagents and methods | |
AU4642600A (en) | Methods and compositions for use in potentiating antigen presentation by antigenpresenting cells | |
AU1796501A (en) | Methods of preparing electrochemical cells | |
AU3916400A (en) | Human transmembrane proteins | |
AU1618500A (en) | Human cell surface receptor proteins | |
AU2001293074A1 (en) | Human liver cell line | |
AU7308200A (en) | Novel hev antigenic peptide and methods | |
AU2001286205A1 (en) | Novel dendritic cell wall membrane and use thereof | |
AU2002213982A1 (en) | Device for determining skin aging in vitro | |
AU3215800A (en) | Identification of broadly reactive hla restricted t cell epitopes | |
AU2002356824A1 (en) | Novel methods for introducing molecules into cells and vectors and compositions for use in such methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |